✨
AI Summary
- Subcutaneous furosemide is bioequivalent to IV administration for heart failure patients.
- Research presented at HFSA Annual Scientific Meeting 2026 by MannKind representatives.
- Potential for improved outpatient management of heart failure symptoms.
Guests on This Episode
AC
Alice Chan
Ph.D. University of California, San Diego 2019 · 1 podcast appearance
BC
Barbara Cornelius
1 podcast appearance
TO
Tochi Okwueze
1 podcast appearance